Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: amino acid substitutions in the core region and low-density lipoprotein cholesterol levels. [electronic resource]
- Journal of hepatology Mar 2007
- 403-10 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
0168-8278
10.1016/j.jhep.2006.09.019 doi
Adult Aged Amino Acid Substitution Antiviral Agents--pharmacology Cholesterol, LDL--blood Drug Therapy, Combination Female Genotype Hepacivirus--drug effects Hepatitis C--blood Humans Interferon alpha-2 Interferon-alpha--pharmacology Japan Male Middle Aged Multivariate Analysis Polyethylene Glycols--pharmacology Predictive Value of Tests Recombinant Proteins Ribavirin--pharmacology Sensitivity and Specificity Treatment Outcome Viral Core Proteins--blood